149 related articles for article (PubMed ID: 6200978)
1. Further molecular and functional evidence for the expression of H-2 allodeterminants on the AKR leukemia, K36.
Festenstein H; Alonzo AD; Ferluga J; Ma BL; Santamaria M; Marelli O; Schmidt W; Flavell RA
Transplant Proc; 1983 Dec; 15(4):2107-10. PubMed ID: 6200978
[No Abstract] [Full Text] [Related]
2. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.
Hui KM; Sim T; Foo TT; Oei AA
J Immunol; 1989 Dec; 143(11):3835-43. PubMed ID: 2584720
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic and associative recognition determinants of H-2 molecules.
Clark SS; Forman J
Transplant Proc; 1983 Dec; 15(4):2090-2. PubMed ID: 6200976
[TBL] [Abstract][Full Text] [Related]
4. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
5. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
6. Variation in MHC antigenic profiles of tumor cells and its biological effects.
Festenstein H; Schmidt W
Immunol Rev; 1981; 60():85-127. PubMed ID: 6171505
[No Abstract] [Full Text] [Related]
7. Serologic and immunochemical studies of the cell membrane alloantigens of K36, an AKR spontaneous leukemia.
Schmidt W; Festenstein H; Atfield G
Transplant Proc; 1980 Mar; 12(1):29-31. PubMed ID: 7368291
[No Abstract] [Full Text] [Related]
8. Biologic effects of the altered MHS profile on the K36 tumor, a spontaneous leukemia of AKR.
Festenstein H; Schmidt W; Testorelli C; Marelli O; Simpson S
Transplant Proc; 1980 Mar; 12(1):25-8. PubMed ID: 7368290
[No Abstract] [Full Text] [Related]
9. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
Green WR
J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
[TBL] [Abstract][Full Text] [Related]
10. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
Green WR
J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
[No Abstract] [Full Text] [Related]
11. Structural changes in class I MHC molecules influencing recognition by allo- or self + TNP-reactive cytotoxic T-cell clones and by monoclonal antibodies.
Davignon JL; Albert F; Boyer C; Hua C; Buferne M; Guimezanes A; Schmitt-Verhulst AM
Transplant Proc; 1983 Dec; 15(4):2080-5. PubMed ID: 6608811
[No Abstract] [Full Text] [Related]
12. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
Green WR
J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
[No Abstract] [Full Text] [Related]
13. The expression of an "alloantigen"-like molecule is a general phenomenon in AKR leukaemias.
Labeta M; Fernandez N; Festenstein H
Transplant Proc; 1989 Feb; 21(1 Pt 1):578. PubMed ID: 2705236
[No Abstract] [Full Text] [Related]
14. Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype.
Sabapathy TK; Cheng Q; Hui KM
Cell Immunol; 1995 Nov; 166(1):141-53. PubMed ID: 7585974
[TBL] [Abstract][Full Text] [Related]
15. Characterization of "foreign" alloantigen-like specificities on a murine lymphoma cell line.
Finke JH; Fyfe DA; Del Villano BC; Butler GH; Ponzio NM
Transplant Proc; 1980 Mar; 12(1):53-8. PubMed ID: 6154359
[No Abstract] [Full Text] [Related]
16. Recognition of GIX-linked minor histocompatibility antigens by H-2-restricted cytotoxic T lymphocytes from C57BL/6-GIX+ mice: an approach to mapping the genes controlling GIX.
Green WR
J Immunol; 1982 Feb; 128(2):920-5. PubMed ID: 6172516
[No Abstract] [Full Text] [Related]
17. Specificity and regulation of cytotoxic T-lymphocyte responses analyzed with H-2 mutants.
Melief CJ; Stukart MJ; de Waal LP; Kast WM; Melvold RW
Transplant Proc; 1983 Dec; 15(4):2086-9. PubMed ID: 6324427
[No Abstract] [Full Text] [Related]
18. Changes in H-2 antigen expression on a murine spontaneous leukaemia (K36) detected by cell-mediated cytotoxicity assay.
Testorelli C; Marelli O; Schmidt W; Festenstein H
J Immunogenet; 1980 Feb; 7(1):19-29. PubMed ID: 6154749
[No Abstract] [Full Text] [Related]
19. Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia.
Schmidt W; Festenstein H
Immunogenetics; 1982; 16(3):257-64. PubMed ID: 6982849
[TBL] [Abstract][Full Text] [Related]
20. Linked help in the cytotoxic T-cell response revealed by adoptive transfer.
Mitchison NA
Transplant Proc; 1983 Dec; 15(4):2121-4. PubMed ID: 6608812
[No Abstract] [Full Text] [Related]
[Next] [New Search]
